| 1 | Taming Lynch Syndrome: The Remarkable Power of Prevention for One Family | 0.9 | 0 | Citations (PDF) |
| 2 | Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial | 33.0 | 45 | Citations (PDF) |
| 3 | A Blood-Based Assay for Detection of Patients with Advanced Adenomas | 2.8 | 0 | Citations (PDF) |
| 4 | Fragmentation signatures in cancer patients resemble those of patients with vascular or autoimmune diseases | 7.5 | 3 | Citations (PDF) |
| 5 | Minimizing and quantifying uncertainty in AI-informed decisions: Applications in medicine | 7.5 | 1 | Citations (PDF) |
| 6 | Machine learning to detect the SINEs of cancer | 12.5 | 21 | Citations (PDF) |
| 7 | ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1 | 1.6 | 1 | Citations (PDF) |
| 8 | TRBC1-targeting antibody–drug conjugates for the treatment of T cell cancers | 37.9 | 39 | Citations (PDF) |
| 9 | Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscape | 1.6 | 6 | Citations (PDF) |
| 10 | Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities | 12.5 | 19 | Citations (PDF) |
| 11 | The rapid and highly parallel identification of antibodies with defined biological activities by SLISY | 13.7 | 7 | Citations (PDF) |
| 12 | Detection of rare mutations, copy number alterations, and methylation in the same template DNA molecules | 7.5 | 30 | Citations (PDF) |
| 13 | Radiologists' Expectations of Artificial Intelligence in Pancreatic Cancer Imaging: How Good Is Good Enough? | 1.0 | 7 | Citations (PDF) |
| 14 | Hydrophobic interactions dominate the recognition of a KRAS G12V neoantigen | 13.7 | 24 | Citations (PDF) |
| 15 | The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer | 25.1 | 121 | Citations (PDF) |
| 16 | TCR-mimic bispecific antibodies to target the HIV-1 reservoir | 7.5 | 19 | Citations (PDF) |
| 17 | An isogenic cell line panel for sequence-based screening of targeted anticancer drugs | 3.6 | 10 | Citations (PDF) |
| 18 | Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer | 34.6 | 797 | Citations (PDF) |
| 19 | Classification of pancreatic cystic neoplasms using radiomic feature analysis is equivalent to an experienced academic radiologist: a step toward computer-augmented diagnostics for radiologists | 1.7 | 29 | Citations (PDF) |
| 20 | Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies | 4.3 | 99 | Citations (PDF) |
| 21 | Association of α1-Blocker Receipt With 30-Day Mortality and Risk of Intensive Care Unit Admission Among Adults Hospitalized With Influenza or Pneumonia in Denmark | 6.6 | 14 | Citations (PDF) |
| 22 | Bispecific antibodies targeting mutantRASneoantigens | 13.4 | 160 | Citations (PDF) |
| 23 | Targeting loss of heterozygosity for cancer-specific immunotherapy | 7.5 | 62 | Citations (PDF) |
| 24 | TCR β chain–directed bispecific antibodies for the treatment of T cell cancers | 12.5 | 53 | Citations (PDF) |
| 25 | The Association Between Alpha-1 Adrenergic Receptor Antagonists and In-Hospital Mortality From COVID-19 | 2.4 | 29 | Citations (PDF) |
| 26 | Targeting a neoantigen derived from a common
TP53
mutation | 36.2 | 321 | Citations (PDF) |
| 27 | Massively Parallel Sequencing of Esophageal Brushings Enables an Aneuploidy-Based Classification of Patients With Barrett’s Esophagus | 0.9 | 29 | Citations (PDF) |
| 28 | Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study | 8.1 | 159 | Citations (PDF) |
| 29 | Detection of low-frequency DNA variants by targeted sequencing of the Watson and Crick strands | 29.8 | 80 | Citations (PDF) |
| 30 | Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers | 37.9 | 451 | Citations (PDF) |
| 31 | Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens | 13.7 | 36 | Citations (PDF) |
| 32 | Revisiting the tumorigenesis timeline with a data-driven generative model | 7.5 | 55 | Citations (PDF) |
| 33 | Assessing aneuploidy with repetitive element sequencing | 7.5 | 75 | Citations (PDF) |
| 34 | Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention | 36.2 | 555 | Citations (PDF) |
| 35 | A multimodality test to guide the management of patients with a pancreatic cyst | 12.5 | 190 | Citations (PDF) |
| 36 | p53: a tumor suppressor hiding in plain sight | 3.5 | 14 | Citations (PDF) |
| 37 | Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer | 14.4 | 558 | Citations (PDF) |
| 38 | Application of Deep Learning to Pancreatic Cancer Detection: Lessons Learned From Our Initial Experience | 2.3 | 81 | Citations (PDF) |
| 39 | An engineered antibody fragment targeting mutant β-catenin via major histocompatibility complex I neoantigen presentation | 2.2 | 22 | Citations (PDF) |
| 40 | The potential role of circulating tumor DNA (ctDNA) in the further investigation of colorectal cancer patients with nonspecific findings on standard investigations | 4.3 | 21 | Citations (PDF) |
| 41 | An analysis of genetic heterogeneity in untreated cancers | 60.8 | 192 | Citations (PDF) |
| 42 | Applications of liquid biopsies for cancer | 12.5 | 185 | Citations (PDF) |
| 43 | Direct Detection and Quantification of Neoantigens | 4.2 | 63 | Citations (PDF) |
| 44 | Cell division rates decrease with age, providing a potential explanation for the age-dependent deceleration in cancer incidence | 7.5 | 82 | Citations (PDF) |
| 45 | Prognostic Potential of Circulating Tumor DNA Measurement in Postoperative Surveillance of Nonmetastatic Colorectal Cancer | 14.4 | 195 | Citations (PDF) |
| 46 | Utility of CT Radiomics Features in Differentiation of Pancreatic Ductal Adenocarcinoma From Normal Pancreatic Tissue | 4.1 | 173 | Citations (PDF) |
| 47 | Incidence and distribution of UroSEEK gene panel in a multi-institutional cohort of bladder urothelial carcinoma | 4.8 | 60 | Citations (PDF) |
| 48 | Persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1 2019, 7, | | 45 | Citations (PDF) |
| 49 | Targeted sequencing of plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutations | 2.3 | 37 | Citations (PDF) |
| 50 | Performance of novel non-invasive urine assay UroSEEK in cohorts of equivocal urine cytology | 2.9 | 35 | Citations (PDF) |
| 51 | Detection of aneuploidy in patients with cancer through amplification of long interspersed nucleotide elements (LINEs) | 7.5 | 58 | Citations (PDF) |
| 52 | Deep Learning in Radiology: Now the Real Work Begins | 2.3 | 19 | Citations (PDF) |
| 53 | Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers | 12.5 | 222 | Citations (PDF) |
| 54 | Genomic analysis identifies frequent deletions of Dystrophin in olfactory neuroblastoma | 13.7 | 38 | Citations (PDF) |
| 55 | Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome | 37.9 | 250 | Citations (PDF) |
| 56 | Precancerous neoplastic cells can move through the pancreatic ductal system | 37.9 | 119 | Citations (PDF) |
| 57 | A novel approach for selecting combination clinical markers of pathology applied to a large retrospective cohort of surgically resected pancreatic cysts | 3.5 | 35 | Citations (PDF) |
| 58 | Identification of allosteric binding sites for PI3Kα oncogenic mutant specific inhibitor design | 2.6 | 32 | Citations (PDF) |
| 59 | Reconstructing metastatic seeding patterns of human cancers | 13.7 | 135 | Citations (PDF) |
| 60 | Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer | 25.2 | 382 | Citations (PDF) |
| 61 | Bisulfite-converted duplexes for the strand-specific detection and quantification of rare mutations | 7.5 | 16 | Citations (PDF) |
| 62 | Cancer-Associated Mutations in Endometriosis without Cancer | 34.6 | 560 | Citations (PDF) |
| 63 | Spectrum of genetic mutations in de novo PUNLMP of the urinary bladder | 2.9 | 34 | Citations (PDF) |
| 64 | Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers | 7.5 | 534 | Citations (PDF) |
| 65 | Selected reaction monitoring approach for validating peptide biomarkers | 7.5 | 37 | Citations (PDF) |
| 66 | Necessity Is the Mother of Invention: The Development of Digital Genomics | 1.1 | 2 | Citations (PDF) |
| 67 | High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma | 2.9 | 42 | Citations (PDF) |
| 68 | Aristolochic Acid in the Etiology of Renal Cell Carcinoma | 1.1 | 78 | Citations (PDF) |
| 69 | Genome-wide quantification of rare somatic mutations in normal human tissues using massively parallel sequencing | 7.5 | 221 | Citations (PDF) |
| 70 | Evaluating the evaluation of cancer driver genes | 7.5 | 379 | Citations (PDF) |
| 71 | Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer | 12.5 | 1,259 | Citations (PDF) |
| 72 | Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer | 13.7 | 258 | Citations (PDF) |
| 73 | Genomic Sequencing Identifies ELF3 as a Driver of Ampullary Carcinoma | 33.0 | 166 | Citations (PDF) |
| 74 | Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer | 25.1 | 334 | Citations (PDF) |
| 75 | Whole-Genome Sequencing of Salivary Gland Adenoid Cystic Carcinoma | 1.5 | 92 | Citations (PDF) |
| 76 | Detection of TERT promoter mutations in primary adenocarcinoma of the urinary bladder | 2.3 | 36 | Citations (PDF) |
| 77 | High prevalence of TERT promoter mutations in primary squamous cell carcinoma of the urinary bladder | 4.8 | 38 | Citations (PDF) |
| 78 | Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease−Associated Colorectal Cancers | 0.9 | 253 | Citations (PDF) |
| 79 | Deregulation of energy metabolism promotes antifibrotic effects in human hepatic stellate cells and prevents liver fibrosis in a mouse model | 2.1 | 35 | Citations (PDF) |
| 80 | PD-1 Blockade in Tumors with Mismatch-Repair Deficiency | 34.6 | 8,849 | Citations (PDF) |
| 81 | Very Long-term Survival Following Resection for Pancreatic Cancer Is Not Explained by Commonly Mutated Genes: Results of Whole-Exome Sequencing Analysis | 6.8 | 92 | Citations (PDF) |
| 82 | Generation of MANAbodies specific to HLA-restricted epitopes encoded by somatically mutated genes | 7.5 | 59 | Citations (PDF) |
| 83 | A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts | 0.9 | 435 | Citations (PDF) |
| 84 | Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas | 12.5 | 450 | Citations (PDF) |
| 85 | Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord | 7.5 | 397 | Citations (PDF) |
| 86 | Enrichment and Expansion with Nanoscale Artificial Antigen Presenting Cells for Adoptive Immunotherapy | 15.3 | 141 | Citations (PDF) |
| 87 | Mutation of the
TERT
promoter, switch to active chromatin, and monoallelic
TERT
expression in multiple cancers | 4.6 | 191 | Citations (PDF) |
| 88 | Widespread somatic L1 retrotransposition occurs early during gastrointestinal cancer evolution | 4.6 | 136 | Citations (PDF) |
| 89 | A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneity | 37.9 | 503 | Citations (PDF) |
| 90 | Lavage of the Uterine Cavity for Molecular Detection of Müllerian Duct Carcinomas: A Proof-of-Concept Study | 16.9 | 107 | Citations (PDF) |
| 91 | Only three driver gene mutations are required for the development of lung and colorectal cancers | 7.5 | 378 | Citations (PDF) |
| 92 | Intraductal papillary mucinous neoplasm in a neonate with congenital hyperinsulinism and a de novo germline SKIL gene mutation | 0.7 | 9 | Citations (PDF) |
| 93 | The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints | 25.1 | 1,374 | Citations (PDF) |
| 94 | Clinical, genomic, and metagenomic characterization of oral tongue squamous cell carcinoma in patients who do not smoke | 2.0 | 74 | Citations (PDF) |
| 95 | Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies | 12.5 | 4,369 | Citations (PDF) |
| 96 | Remote loading of preencapsulated drugs into stealth liposomes | 7.5 | 131 | Citations (PDF) |
| 97 | Exomic analysis of myxoid liposarcomas, synovial sarcomas, and osteosarcomas | 3.0 | 100 | Citations (PDF) |
| 98 | Whole‐exome sequencing of pancreatic neoplasms with acinar differentiation | 4.9 | 172 | Citations (PDF) |
| 99 | Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells | 7.5 | 654 | Citations (PDF) |
| 100 | Microbiota organization is a distinct feature of proximal colorectal cancers | 7.5 | 661 | Citations (PDF) |
| 101 | GNAS Sequencing Identifies IPMN-specific Mutations in a Subgroup of Diminutive Pancreatic Cysts Referred to as “Incipient IPMNs” | 3.5 | 58 | Citations (PDF) |
| 102 | Detection of Somatic TP53 Mutations in Tampons of Patients With High-Grade Serous Ovarian Cancer | 1.9 | 51 | Citations (PDF) |
| 103 | Intratumoral injection of
Clostridium novyi
-NT spores induces antitumor responses | 12.5 | 351 | Citations (PDF) |
| 104 | A diaCEST MRI approach for monitoring liposomal accumulation in tumors | 11.0 | 57 | Citations (PDF) |
| 105 | Association of the Autoimmune Disease Scleroderma with an Immunologic Response to Cancer | 36.2 | 404 | Citations (PDF) |
| 106 | Systemic Delivery of Microencapsulated 3-Bromopyruvate for the Therapy of Pancreatic Cancer | 6.8 | 56 | Citations (PDF) |
| 107 | Activation of diverse signalling pathways by oncogenic PIK3CA mutations | 13.7 | 84 | Citations (PDF) |
| 108 | Somatic mutations of SUZ12 in malignant peripheral nerve sheath tumors | 25.2 | 284 | Citations (PDF) |
| 109 | The Early Detection of Pancreatic Cancer: What Will It Take to Diagnose and Treat Curable Pancreatic Neoplasia? | 3.8 | 234 | Citations (PDF) |
| 110 | Familial and sporadic pancreatic cancer share the same molecular pathogenesis | 1.4 | 59 | Citations (PDF) |
| 111 | Limited detection of IgH gene rearrangements in plasma of patients with primary central nervous system lymphoma | 2.5 | 5 | Citations (PDF) |
| 112 | Clinicopathological Correlates of Activating GNAS Mutations in Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas | 2.3 | 171 | Citations (PDF) |
| 113 | Cancer Genome Landscapes | 36.2 | 7,297 | Citations (PDF) |
| 114 | A nanoparticle formulation that selectively transfects metastatic tumors in mice | 7.5 | 68 | Citations (PDF) |
| 115 | Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas | 25.2 | 617 | Citations (PDF) |
| 116 | Mutational Signature of Aristolochic Acid Exposure as Revealed by Whole-Exome Sequencing | 12.5 | 247 | Citations (PDF) |
| 117 | TERT
promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal | 7.5 | 1,325 | Citations (PDF) |
| 118 | Evaluation of DNA from the Papanicolaou Test to Detect Ovarian and Endometrial Cancers | 12.5 | 297 | Citations (PDF) |
| 119 | Exomic Sequencing of Medullary Thyroid Cancer Reveals Dominant and Mutually Exclusive Oncogenic Mutations in RET and RAS | 4.1 | 245 | Citations (PDF) |
| 120 | Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation | 7.5 | 374 | Citations (PDF) |
| 121 | Noninvasive imaging of infection after treatment with tumor‐homing bacteria using Chemical Exchange Saturation Transfer (CEST) MRI | 2.8 | 46 | Citations (PDF) |
| 122 | ATM
Mutations in Patients with Hereditary Pancreatic Cancer | 25.1 | 473 | Citations (PDF) |
| 123 | Definition of the binding mode of a new class of phosphoinositide 3-kinase α-selective inhibitors using in vitro mutagenesis of non-conserved amino acids and kinetic analysis | 3.8 | 27 | Citations (PDF) |
| 124 | Loss of ATRX, Genome Instability, and an Altered DNA Damage Response Are Hallmarks of the Alternative Lengthening of Telomeres Pathway | 3.2 | 567 | Citations (PDF) |
| 125 | Somatic Mutations in CCK2R Alter Receptor Activity that Promote Oncogenic Phenotypes | 3.1 | 18 | Citations (PDF) |
| 126 | Response to Comments on “The Predictive Capacity of Personal Genome Sequencing” | 12.5 | 1 | Citations (PDF) |
| 127 | Comparative Genomic Analysis of Esophageal Adenocarcinoma and Squamous Cell Carcinoma | 25.1 | 360 | Citations (PDF) |
| 128 | Detection of Chromosomal Alterations in the Circulation of Cancer Patients with Whole-Genome Sequencing | 12.5 | 594 | Citations (PDF) |
| 129 | GNAS codon 201 mutations are uncommon in intraductal papillary neoplasms of the bile duct | 0.3 | 51 | Citations (PDF) |
| 130 | Presence of Somatic Mutations in Most Early-Stage Pancreatic Intraepithelial Neoplasia | 0.9 | 670 | Citations (PDF) |
| 131 | Low‐grade serous carcinomas of the ovary contain very few point mutations | 4.9 | 203 | Citations (PDF) |
| 132 | The Predictive Capacity of Personal Genome Sequencing | 12.5 | 173 | Citations (PDF) |
| 133 | Next-Generation Stool DNA Test Accurately Detects Colorectal Cancer and Large Adenomas | 0.9 | 295 | Citations (PDF) |
| 134 | The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers | 37.9 | 1,600 | Citations (PDF) |
| 135 | Genetically Defined Subsets of Human Pancreatic Cancer Show Unique
In Vitro
Chemosensitivity | 6.8 | 66 | Citations (PDF) |
| 136 | Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma | 25.2 | 410 | Citations (PDF) |
| 137 | FAST-SeqS: A Simple and Efficient Method for the Detection of Aneuploidy by Massively Parallel Sequencing | 2.3 | 73 | Citations (PDF) |
| 138 | Mutant proteins as cancer-specific biomarkers | 7.5 | 171 | Citations (PDF) |
| 139 | Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma | 25.2 | 407 | Citations (PDF) |
| 140 | The Genetic Landscape of the Childhood Cancer Medulloblastoma | 36.2 | 683 | Citations (PDF) |
| 141 | Detection and quantification of rare mutations with massively parallel sequencing | 7.5 | 1,150 | Citations (PDF) |
| 142 | Thiazolidinedione‐Based PI3Kα Inhibitors: An Analysis of Biochemical and Virtual Screening Methods | 3.1 | 15 | Citations (PDF) |
| 143 | Detection of Tumor DNA at the Margins of Colorectal Cancer Liver Metastasis | 6.8 | 44 | Citations (PDF) |
| 144 | Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome | 7.5 | 420 | Citations (PDF) |
| 145 | Recurrent
GNAS
Mutations Define an Unexpected Pathway for Pancreatic Cyst Development | 12.5 | 748 | Citations (PDF) |
| 146 | 14-3-3σ regulates B-cell homeostasis through stabilization of FOXO1 | 7.5 | 36 | Citations (PDF) |
| 147 | Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways | 7.5 | 618 | Citations (PDF) |
| 148 | The Temporal Order of Genetic and Pathway Alterations in Tumorigenesis | 2.3 | 104 | Citations (PDF) |
| 149 | Somatic mutations in PI3Kα: Structural basis for enzyme activation and drug design | 2.0 | 19 | Citations (PDF) |
| 150 | Knock in of the AKT1 E17K mutation in human breast epithelial cells does not recapitulate oncogenic PIK3CA mutations | 6.5 | 55 | Citations (PDF) |
| 151 | Heteroplasmic mitochondrial DNA mutations in normal and tumour cells | 37.9 | 494 | Citations (PDF) |
| 152 | Distant metastasis occurs late during the genetic evolution of pancreatic cancer | 37.9 | 2,329 | Citations (PDF) |
| 153 | Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing | 12.5 | 468 | Citations (PDF) |
| 154 | Genetic inactivation of
AKT1
,
AKT2
, and
PDPK1
in human colorectal cancer cells clarifies their roles in tumor growth regulation | 7.5 | 121 | Citations (PDF) |
| 155 | Accumulation of driver and passenger mutations during tumor progression | 7.5 | 803 | Citations (PDF) |
| 156 | Patient-oriented gene set analysis for cancer mutation data | 8.1 | 66 | Citations (PDF) |
| 157 | Identification of Somatically Acquired Gene Mutations In the Kineome and Exome In CLLBlood, 2010, 116, 2410-2410 | 4.2 | 0 | Citations (PDF) |
| 158 | A frequent kinase domain mutation that changes the interaction between PI3Kα and the membrane | 7.5 | 290 | Citations (PDF) |
| 159 | Inactivating germ-line and somatic mutations in polypeptide
N
-acetylgalactosaminyltransferase 12 in human colon cancers | 7.5 | 137 | Citations (PDF) |
| 160 | A panel of isogenic human cancer cells suggests a therapeutic approach for cancers with inactivated p53 | 7.5 | 286 | Citations (PDF) |
| 161 | Sensitive digital quantification of DNA methylation in clinical samples | 29.8 | 334 | Citations (PDF) |
| 162 | Design and analysis issues in genome-wide somatic mutation studies of cancer | 2.8 | 86 | Citations (PDF) |
| 163 | IDH1 and IDH2 Mutations in Gliomas | 34.6 | 5,815 | Citations (PDF) |
| 164 | Cancer-Specific High-Throughput Annotation of Somatic Mutations: Computational Prediction of Driver Missense Mutations | 3.8 | 445 | Citations (PDF) |
| 165 | Structural comparisons of class I phosphoinositide 3-kinases | 60.8 | 98 | Citations (PDF) |
| 166 | Genome-wide linkage scan for colorectal cancer susceptibility genes supports linkage to chromosome 3q | 2.9 | 35 | Citations (PDF) |
| 167 | Analysis of Mutations in DNA Isolated From Plasma and Stool of Colorectal Cancer Patients | 0.9 | 216 | Citations (PDF) |
| 168 | Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers | 7.5 | 382 | Citations (PDF) |
| 169 | Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers | 7.5 | 300 | Citations (PDF) |
| 170 | Comparative lesion sequencing provides insights into tumor evolution | 7.5 | 773 | Citations (PDF) |
| 171 | Dissecting isoform selectivity of PI3K inhibitors: the role of non-conserved residues in the catalytic pocket | 3.8 | 51 | Citations (PDF) |
| 172 | Identification of STAT3 as a substrate of receptor protein tyrosine phosphatase T | 7.5 | 202 | Citations (PDF) |
| 173 | Genetic Progression and the Waiting Time to Cancer | 3.1 | 352 | Citations (PDF) |
| 174 | Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) Diagnostics | 4.6 | 202 | Citations (PDF) |
| 175 | Spore Coat Architecture of
Clostridium novyi
NT Spores | 2.9 | 48 | Citations (PDF) |
| 176 | A multidimensional analysis of genes mutated in breast and colorectal cancers | 4.6 | 121 | Citations (PDF) |
| 177 | Facultative or obligate anaerobic bacteria have the potential for multimodality therapy of solid tumours | 4.9 | 100 | Citations (PDF) |
| 178 | Imaging of Musculoskeletal Bacterial Infections by [124I]FIAU-PET/CT | 2.3 | 91 | Citations (PDF) |
| 179 | Development and validation of a liquid chromatography/tandem mass spectrometry method for the determination of DMXAA in human and mouse plasma | 2.6 | 2 | Citations (PDF) |
| 180 | The role of companion diagnostics in the development and use of mutation-targeted cancer therapies | 29.8 | 132 | Citations (PDF) |
| 181 | The genome and transcriptomes of the anti-tumor agent Clostridium novyi-NT | 29.8 | 147 | Citations (PDF) |
| 182 | BEAMing up for detection and quantification of rare sequence variants | 24.6 | 264 | Citations (PDF) |
| 183 | Somatic mutations ofGUCY2F,EPHA3, andNTRK3 in human cancers | 4.5 | 90 | Citations (PDF) |
| 184 | Tumor endothelial marker 1 (Tem1) functions in the growth and progression of abdominal tumors | 7.5 | 141 | Citations (PDF) |
| 185 | The colorectal microRNAome | 7.5 | 902 | Citations (PDF) |
| 186 | Discodermolide analogues as the chemical component of combination bacteriolytic therapy | 2.0 | 34 | Citations (PDF) |
| 187 | Contribution of bone marrow–derived endothelial cells to human tumor vasculature | 33.0 | 475 | Citations (PDF) |
| 188 | Mutations in a signalling pathway | 37.9 | 525 | Citations (PDF) |
| 189 | Mutant PIK3CA promotes cell growth and invasion of human cancer cells | 33.0 | 872 | Citations (PDF) |
| 190 | Can chromosomal instability initiate tumorigenesis? | 13.7 | 183 | Citations (PDF) |
| 191 | Detection and quantification of mutations in the plasma of patients with colorectal tumors | 7.5 | 1,118 | Citations (PDF) |
| 192 | Pharmacologic and Toxicologic Evaluation of C. novyi-NT Spores | 3.8 | 104 | Citations (PDF) |
| 193 | Imaging bacterial infections with radiolabeled 1-(2'-deoxy-2'-fluoro- -D-arabinofuranosyl)-5-iodouracil | 7.5 | 128 | Citations (PDF) |
| 194 | Targeting Vascular and Avascular Compartments of Tumors withC. novyi-NTand Anti-microtubule Agents | 4.1 | 100 | Citations (PDF) |
| 195 | Facile methods for generating human somatic cell gene knockouts using recombinant adeno-associated viruses | 15.5 | 149 | Citations (PDF) |
| 196 | SMAC/Diablo-dependent apoptosis induced by nonsteroidal antiinflammatory drugs (NSAIDs) in colon cancer cells | 7.5 | 73 | Citations (PDF) |
| 197 | Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients | 7.5 | 180 | Citations (PDF) |
| 198 | Bacteriolytic therapy can generate a potent immune response against experimental tumors | 7.5 | 278 | Citations (PDF) |
| 199 | Cancer genes and the pathways they control | 33.0 | 3,871 | Citations (PDF) |
| 200 | Inactivation of hCDC4 can cause chromosomal instability | 37.9 | 524 | Citations (PDF) |
| 201 | Synthesis and evaluation of aminophosphinic acid derivatives as inhibitors of renal dipeptidase | 2.0 | 12 | Citations (PDF) |
| 202 | Somatic Mutations of EGFR in Colorectal Cancers and Glioblastomas | 34.6 | 296 | Citations (PDF) |
| 203 | Knudson's hypothesis and theTP53 revolution | 3.0 | 11 | Citations (PDF) |
| 204 | Design, synthesis and evaluation of new RDP inhibitors | 1.4 | 13 | Citations (PDF) |
| 205 | Multicolor in vitro translation | 29.8 | 27 | Citations (PDF) |
| 206 | The significance of unstable chromosomes in colorectal cancer | 60.8 | 432 | Citations (PDF) |
| 207 | Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations | 7.5 | 786 | Citations (PDF) |
| 208 | Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria | 7.5 | 161 | Citations (PDF) |
| 209 | PUMA mediates the apoptotic response to p53 in colorectal cancer cells | 7.5 | 550 | Citations (PDF) |
| 210 | The Chk2 Tumor Suppressor Is Not Required for p53 Responses in Human Cancer Cells | 2.2 | 135 | Citations (PDF) |
| 211 | The role of chromosomal instability in tumor initiation | 7.5 | 506 | Citations (PDF) |
| 212 | Digital karyotyping | 7.5 | 218 | Citations (PDF) |
| 213 | Targeted inactivation of CTNNB1 reveals unexpected effects of -catenin mutation | 7.5 | 124 | Citations (PDF) |
| 214 | DEC1 is a downstream target of TGF- with sequence-specific transcriptional repressor activities | 7.5 | 86 | Citations (PDF) |
| 215 | GENETICS: Please Don't Call It Cloning! | 36.2 | 63 | Citations (PDF) |
| 216 | Dynamics of Genetic Instability in Sporadic and Familial Colorectal Cancer | 4.1 | 69 | Citations (PDF) |
| 217 | Detection of APC Mutations in Fecal DNA from Patients with Colorectal Tumors | 34.6 | 328 | Citations (PDF) |
| 218 | Prevalence of somatic alterations in the colorectal cancer cell genome | 7.5 | 176 | Citations (PDF) |
| 219 | Counting alleles to predict recurrence of early-stage colorectal cancers | 62.3 | 143 | Citations (PDF) |
| 220 | Detection of proximal colorectal cancers through analysis of faecal DNA | 62.3 | 142 | Citations (PDF) |
| 221 | DNMT1 and DNMT3b cooperate to silence genes in human cancer cells | 37.9 | 1,165 | Citations (PDF) |
| 222 | RAF/RAS oncogenes and mismatch-repair status | 37.9 | 1,152 | Citations (PDF) |
| 223 | PUMA Induces the Rapid Apoptosis of Colorectal Cancer Cells | 13.3 | 1,196 | Citations (PDF) |
| 224 | Securin Is Required for Chromosomal Stability in Human Cells | 33.7 | 380 | Citations (PDF) |
| 225 | Combination bacteriolytic therapy for the treatment of experimental tumors | 7.5 | 524 | Citations (PDF) |
| 226 | Mutation Screening of the TNFRSF11A Gene Encoding Receptor Activator of NFkB (RANK) in Familial and Sporadic Paget's Disease of Bone and Osteosarcoma | 2.8 | 76 | Citations (PDF) |
| 227 | Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis | 25.2 | 604 | Citations (PDF) |
| 228 | Use of isogenic human cancer cells for high-throughput screening and drug discovery | 29.8 | 247 | Citations (PDF) |
| 229 | Ferredoxin reductase affects p53-dependent, 5-fluorouracil–induced apoptosis in colorectal cancer cells | 33.0 | 410 | Citations (PDF) |
| 230 | Detecting Colorectal Cancer in Stool With the Use of Multiple Genetic Targets | 4.6 | 561 | Citations (PDF) |
| 231 | Genetic disruption of PPAR decreases the tumorigenicity of human colon cancer cells | 7.5 | 243 | Citations (PDF) |
| 232 | Mechanisms underlying losses of heterozygosity in human colorectal cancers | 7.5 | 206 | Citations (PDF) |
| 233 | Top-down morphogenesis of colorectal tumors | 7.5 | 337 | Citations (PDF) |
| 234 | Carcinogen-specific induction of genetic instability | 7.5 | 155 | Citations (PDF) |
| 235 | Small changes in expression affect predisposition to tumorigenesis | 25.2 | 237 | Citations (PDF) |
| 236 | Combinatorial chemoprevention of intestinal neoplasia | 33.0 | 507 | Citations (PDF) |
| 237 | Conversion of diploidy to haploidy | 37.9 | 249 | Citations (PDF) |
| 238 | CpG methylation is maintained in human cancer cells lacking DNMT1 | 37.9 | 424 | Citations (PDF) |
| 239 | p53-dependent expression of PIG3 during proliferation, genotoxic stress, and reversible growth arrest | 8.6 | 79 | Citations (PDF) |
| 240 | Cooperative effects of genes controlling the G2/M checkpoint | 4.6 | 228 | Citations (PDF) |
| 241 | Going Mad withSmads | 34.6 | 48 | Citations (PDF) |
| 242 | Analysis of masked mutations in familial adenomatous polyposis | 7.5 | 110 | Citations (PDF) |
| 243 | Identification and classification of p53-regulated genes | 7.5 | 428 | Citations (PDF) |
| 244 | 14-3-3σ is required to prevent mitotic catastrophe after DNA damage | 37.9 | 896 | Citations (PDF) |
| 245 | Analysis of human transcriptomes | 25.2 | 746 | Citations (PDF) |
| 246 | Genetic instability and darwinian selection in tumours | 9.8 | 30 | Citations (PDF) |
| 247 | Genetic instability and darwinian selection in tumours | 12.1 | 655 | Citations (PDF) |
| 248 | Genetic instability and darwinian selection in tumours | 6.7 | 20 | Citations (PDF) |
| 249 | Digital PCR | 7.5 | 1,660 | Citations (PDF) |
| 250 | PPARδ Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory Drugs | 33.7 | 1,078 | Citations (PDF) |
| 251 | Characterization of MAD2B and Other Mitotic Spindle Checkpoint Genes | 2.8 | 216 | Citations (PDF) |
| 252 | Disruption of p53 in human cancer cells alters the responses to therapeutic agents | 10.6 | 950 | Citations (PDF) |
| 253 | Somatic mutations of the mitochondrial genome in human colorectal tumours | 25.2 | 809 | Citations (PDF) |
| 254 | Mutations of mitotic checkpoint genes in human cancers | 37.9 | 1,430 | Citations (PDF) |
| 255 | Genetic instabilities in human cancers | 37.9 | 3,960 | Citations (PDF) |
| 256 | Genotyping by mass spectrometric analysis of short DNA fragments | 29.8 | 112 | Citations (PDF) |
| 257 | Human Smad3 and Smad4 Are Sequence-Specific Transcription Activators | 13.3 | 975 | Citations (PDF) |
| 258 | Characterization of Human FAST-1, a TGFβ and Activin Signal Transducer | 13.3 | 229 | Citations (PDF) |
| 259 | Accumulated Clonal Genetic Alterations in Familial and Sporadic Colorectal Carcinomas with Widespread Instability in Microsatellite Sequences | 3.4 | 183 | Citations (PDF) |
| 260 | Targeted deletion of Smad4 shows it is required for transforming growth factor and activin signaling in colorectal cancer cells | 7.5 | 152 | Citations (PDF) |
| 261 | A Naturally Occurring hPMS2 Mutation Can Confer a Dominant Negative Mutator Phenotype | 2.5 | 97 | Citations (PDF) |
| 262 | Incidence and functional consequences of
hMLH1
promoter hypermethylation in colorectal carcinoma | 7.5 | 1,761 | Citations (PDF) |
| 263 | A simplified system for generating recombinant adenoviruses | 7.5 | 3,369 | Citations (PDF) |
| 264 | Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis | 7.5 | 560 | Citations (PDF) |
| 265 | Cancer risk associated with germline DNA mismatch repair gene mutations | 2.9 | 613 | Citations (PDF) |
| 266 | DNA methylation and genetic instability in colorectal cancer cells | 7.5 | 366 | Citations (PDF) |
| 267 | Is a p53-Regulated Inhibitor of G2/M Progression | 13.3 | 1,184 | Citations (PDF) |
| 268 | Characterization of the Yeast Transcriptome | 33.7 | 1,044 | Citations (PDF) |
| 269 | Less death in the dying | 13.3 | 15 | Citations (PDF) |
| 270 | Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC | 25.2 | 653 | Citations (PDF) |
| 271 | Cell-cycle arrest versus cell death in cancer therapy | 33.0 | 359 | Citations (PDF) |
| 272 | A model for p53-induced apoptosis | 37.9 | 2,445 | Citations (PDF) |
| 273 | Genetic instability in colorectal cancers | 37.9 | 1,854 | Citations (PDF) |
| 274 | Molecular Cloning of the N-Terminus of GTBP | 2.8 | 33 | Citations (PDF) |
| 275 | Lessons from Hereditary Colorectal Cancer | 33.7 | 4,483 | Citations (PDF) |
| 276 | Nomenclature: Vertebrate Mediators of TGFβ Family Signals | 33.7 | 179 | Citations (PDF) |
| 277 | Converting cancer genes into killer genes. | 7.5 | 47 | Citations (PDF) |
| 278 | Mammalian cells resistant to tumor suppressor genes. | 7.5 | 9 | Citations (PDF) |
| 279 | Expression of p21waf1/cip1
, mdm2 and p53 in vivo
: analysis of cytological preparations | 1.0 | 5 | Citations (PDF) |
| 280 | Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers | 25.2 | 592 | Citations (PDF) |
| 281 | Mad-related genes in the human | 25.2 | 361 | Citations (PDF) |
| 282 | Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21 | 37.9 | 735 | Citations (PDF) |
| 283 | SHORT COMMUNICATION: Sulindac suppresses tumorigenesis in the Min mouse | 2.8 | 172 | Citations (PDF) |
| 284 | PAK1, a gene that can regulate p53 activity in yeast. | 7.5 | 26 | Citations (PDF) |
| 285 | Polymerase δ variants in RER colorectal tumours | 25.2 | 131 | Citations (PDF) |
| 286 | Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability | 25.2 | 775 | Citations (PDF) |
| 287 | Monoallelic mutation analysis (MAMA) for identifying germline mutations | 25.2 | 70 | Citations (PDF) |
| 288 | Genetic instability occurs in the majority of young patients with colorectal cancer | 33.0 | 360 | Citations (PDF) |
| 289 | Founding mutations and Alu-mediated recombination in hereditary colon cancer | 33.0 | 280 | Citations (PDF) |
| 290 | Genomic Organization of the HumanPMS2Gene Family | 2.8 | 121 | Citations (PDF) |
| 291 | Analysis of the 5′ Region ofPMS2Reveals Heterogeneous Transcripts and a Novel Overlapping Gene | 2.8 | 41 | Citations (PDF) |
| 292 | The Molecular Basis of Turcot's Syndrome | 34.6 | 1,094 | Citations (PDF) |
| 293 | Allelic Loss of Chromosome 18q and Prognosis in Colorectal Cancer | 34.6 | 697 | Citations (PDF) |
| 294 | An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms | 4.9 | 503 | Citations (PDF) |
| 295 | Lack of association of human polyomaviruses with human brain tumors | 2.5 | 56 | Citations (PDF) |
| 296 | Mutations of two P/WS homologues in hereditary nonpolyposis colon cancer | 37.9 | 1,561 | Citations (PDF) |
| 297 | Cancer Therapy Meets p53 | 34.6 | 79 | Citations (PDF) |
| 298 | Has the breast cancer gene been found? | 33.7 | 113 | Citations (PDF) |
| 299 | The DCC Gene: Structural Analysis and Mutations in Colorectal Carcinomas | 2.8 | 217 | Citations (PDF) |
| 300 | p53 tagged sites from human genomic DNA | 2.9 | 177 | Citations (PDF) |
| 301 | Sequence-specific transcriptional activation is essential for growth suppression by p53. | 7.5 | 371 | Citations (PDF) |
| 302 | Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. | 7.5 | 277 | Citations (PDF) |
| 303 | Colorectal Cancer and the Intersection between Basic and Clinical Research | 1.6 | 27 | Citations (PDF) |
| 304 | Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 | 37.9 | 1,437 | Citations (PDF) |
| 305 | The multistep nature of cancer | 9.8 | 1,687 | Citations (PDF) |
| 306 | Cell adhesion molecules as tumour suppressors | 12.1 | 88 | Citations (PDF) |
| 307 | Mapping of Multiple Intestinal Neoplasia (Min) to Proximal Chromosome 18 of the Mouse | 2.8 | 53 | Citations (PDF) |
| 308 | WAF1, a potential mediator of p53 tumor suppression | 33.7 | 8,296 | Citations (PDF) |
| 309 | Molecular Diagnosis of Familial Adenomatous Polyposis | 34.6 | 672 | Citations (PDF) |
| 310 | In vivocloning of PCR products inE.coli | 15.5 | 122 | Citations (PDF) |
| 311 | Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancerCell, 1993, 75, 1215-1225 | 33.7 | 2,239 | Citations (PDF) |
| 312 | Hypermutability and mismatch repair deficiency in RER+ tumor cellsCell, 1993, 75, 1227-1236 | 33.7 | 1,059 | Citations (PDF) |
| 313 | The APC gene product in normal and tumor cells. | 7.5 | 394 | Citations (PDF) |
| 314 | SAM 1.1 and JOSH 4.4: two RFLPs within the human DCC gene | 2.9 | 9 | Citations (PDF) |
| 315 | The relationship of DNA aneuploidy to molecular genetic alterations in colorectal carcinoma | 0.9 | 114 | Citations (PDF) |
| 316 | The Colorectal Cancer Gene Hunt: Current Findings | 1.0 | 14 | Citations (PDF) |
| 317 | Structural alterations of the epidermal growth factor receptor gene in human gliomas. | 7.5 | 795 | Citations (PDF) |
| 318 | Clonal Origin of Bladder Cancer | 34.6 | 511 | Citations (PDF) |
| 319 | A molecular genetic linkage map of mouse chromosome 18 reveals extensive linkage conservation with human chromosomes 5 and 18 | 2.8 | 46 | Citations (PDF) |
| 320 | p53 function and dysfunction | 33.7 | 2,222 | Citations (PDF) |
| 321 | A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia | 33.7 | 3,044 | Citations (PDF) |
| 322 | Clonal expansion of p53 mutant cells is associated with brain tumour progression | 37.9 | 638 | Citations (PDF) |
| 323 | Amplification of a gene encoding a p53-associated protein in human sarcomas | 37.9 | 1,985 | Citations (PDF) |
| 324 | APC mutations occur early during colorectal tumorigenesis | 37.9 | 1,782 | Citations (PDF) |
| 325 | Insertion/Deletion Polymorphism and Other Restriction Fragment Length Polymorphisms in theMCCGene | 1.8 | 4 | Citations (PDF) |
| 326 | Definition of a consensus binding site for p53 | 25.2 | 1,987 | Citations (PDF) |
| 327 | Suppressor gene alterations in the colorectal adenoma-carcinoma sequence | 3.0 | 68 | Citations (PDF) |
| 328 | Screening for germ-line mutations in familial adenomatous polyposis patients: 61 new patients and a summary of 150 unrelated patients | 4.5 | 115 | Citations (PDF) |
| 329 | Investigation of colon cancers for human papillomavirus genomic sequences by polymerase chain reaction | 1.5 | 44 | Citations (PDF) |
| 330 | Colon cancer genetics | 4.0 | 52 | Citations (PDF) |
| 331 | Genetic alterations in the adenoma–carcinoma sequence | 4.0 | 324 | Citations (PDF) |
| 332 | Human p53 and
CDC2Hs
Genes Combine To Inhibit the Proliferation of
Saccharomyces cerevisiae | 2.5 | 50 | Citations (PDF) |
| 333 | Progression of Colorectal Cancer Is Associated with Multiple Tumor Suppressor Gene Defects but Inhibition of Tumorigenicity Is Accomplished by Correction of Any Single Defect via Chromosome Transfer | 2.5 | 76 | Citations (PDF) |
| 334 | Isolation and Structural Analysis of a 1.2-Megabase N-myc Amplicon from a Human Neuroblastoma | 2.5 | 24 | Citations (PDF) |
| 335 | Scrambled exons | 33.7 | 923 | Citations (PDF) |
| 336 | Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replicationCell, 1991, 65, 1083-1091 | 33.7 | 409 | Citations (PDF) |
| 337 | Immunogenicity of a non-class I MHC expressing murine tumor transfected with the influenza virus hemagglutinin or murine interleukin-2 genes | 4.6 | 4 | Citations (PDF) |
| 338 | HindIIIpolymorphism in the DCC gene | 15.5 | 2 | Citations (PDF) |
| 339 | The Zinc Finger Protein GLI Transforms Primary Cells in Cooperation with Adenovirus E1A | 2.5 | 49 | Citations (PDF) |
| 340 | EcoRI polymorphism within theGLIgene (chromosome 12q13.3–14.1) | 15.5 | 9 | Citations (PDF) |
| 341 | RAS gene mutations in childhood acute myeloid leukemia: A pediatric oncology group study | 3.0 | 45 | Citations (PDF) |
| 342 | Cytogenetics and Molecular Genetics of Malignant Gliomas and Medulloblastoma | 5.0 | 149 | Citations (PDF) |
| 343 | Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response | 33.7 | 935 | Citations (PDF) |
| 344 | A genetic model for colorectal tumorigenesis | 33.7 | 11,373 | Citations (PDF) |
| 345 | GLI3 Encodes a 190-Kilodalton Protein with Multiple Regions of GLI Similarity | 2.5 | 69 | Citations (PDF) |
| 346 | p53 Functions as a Cell Cycle Control Protein in Osteosarcomas | 2.5 | 324 | Citations (PDF) |
| 347 | The
GLI
Gene Encodes a Nuclear Protein Which Binds Specific Sequences in the Human Genome | 2.5 | 241 | Citations (PDF) |
| 348 | Allelic Loss in Colorectal Carcinoma | 16.6 | 263 | Citations (PDF) |
| 349 | Whole genome PCR: application to the identification of sequences bound by gene regulatory protein | 15.5 | 196 | Citations (PDF) |
| 350 | Systemic immunity against a murine colon tumor (CT-26) produced by immunization with syngeneic cells expressing a transfected viral gene product | 4.3 | 24 | Citations (PDF) |
| 351 | Mutations in the p53 gene occur in diverse human tumour types | 37.9 | 2,751 | Citations (PDF) |
| 352 | The GLI gene is a member of the Kruppel family of zinc finger proteins | 37.9 | 386 | Citations (PDF) |
| 353 | Genetic Alterations during Colorectal-Tumor Development | 34.6 | 6,376 | Citations (PDF) |
| 354 | Gene Amplification in Malignant Human Gliomas: Clinical and Histopathologic Aspects | 1.8 | 183 | Citations (PDF) |
| 355 | Carrier detection in the Wiskott Aldrich syndromeBlood, 1988, 72, 1735-1739 | 4.2 | 103 | Citations (PDF) |
| 356 | The GLI-Kruppel Family of Human Genes | 2.5 | 130 | Citations (PDF) |
| 357 | Characterization of N-myc Amplification Units in Human Neuroblastoma Cells | 2.5 | 12 | Citations (PDF) |
| 358 | Carrier Detection in X-Linked Agammaglobulinemia by Analysis of X-Chromosome Inactivation | 34.6 | 165 | Citations (PDF) |
| 359 | Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. | 7.5 | 777 | Citations (PDF) |
| 360 | Relationship between gene amplification and chromosomal deviations in malignant human gliomas | 1.2 | 126 | Citations (PDF) |
| 361 | Alterations in DNA methylation in human colon neoplasia | 2.0 | 50 | Citations (PDF) |
| 362 | Rapid purification of DNA from agarose gels by centrifugation through a disposable plastic column | 2.4 | 29 | Citations (PDF) |
| 363 | Prevalence of ras gene mutations in human colorectal cancers | 37.9 | 1,780 | Citations (PDF) |
| 364 | Gene amplification in cancer: A molecular cytogenetic approach | 1.2 | 13 | Citations (PDF) |
| 365 | Differentiation of Leukemia Cells to Polymorphonuclear Leukocytes in Patients with Acute Nonlymphocytic Leukemia | 34.6 | 296 | Citations (PDF) |
| 366 | Loss of genes on the short arm of chromosome 11 in bladder cancer | 37.9 | 335 | Citations (PDF) |
| 367 | Supercoiled loops and the organization of replication and transcription in eukaryotes | 2.1 | 57 | Citations (PDF) |
| 368 | The anatomy of supercoiled loops in theDrosophila, 7F locus | 15.5 | 24 | Citations (PDF) |
| 369 | The association of transcribed genes with the nuclear matrix ofDrosophilacells during heat shock | 15.5 | 122 | Citations (PDF) |
| 370 | Purification of DNA from formaldehyde fixed and paraffin embedded human tissue | 2.1 | 793 | Citations (PDF) |
| 371 | Somatic deletion and duplication of genes on chromosome 11 in Wilms' tumours | 37.9 | 427 | Citations (PDF) |
| 372 | Hypomethylation distinguishes genes of some human cancers from their normal counterparts | 37.9 | 2,285 | Citations (PDF) |
| 373 | A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity | 2.4 | 24,606 | Citations (PDF) |
| 374 | Hypomethylation of ras oncogenes in primary human cancers | 2.1 | 480 | Citations (PDF) |
| 375 | The association of transcriptionally active genes with the nuclear matrix of the chicken oviduct | 15.5 | 146 | Citations (PDF) |
| 376 | The ovalbumin gene is associated with the nuclear matrix of chicken oviduct cells | 33.7 | 378 | Citations (PDF) |
| 377 | A subset of small nuclear ribonucleoprotein particle antigens is a component of the nuclear matrix | 2.1 | 40 | Citations (PDF) |
| 378 | Increased phosphorylation rate of intermediate filaments during mitotic arrest | 3.1 | 21 | Citations (PDF) |
| 379 | Association of newly replicated DNA with the nuclear matrix of Physarum polycephalum | 15.5 | 65 | Citations (PDF) |
| 380 | Localization of SV40 genes within supercoiled loop domains | 15.5 | 112 | Citations (PDF) |
| 381 | Sequence analysis of nuclear matrix associated DNA from rat liver | 3.1 | 81 | Citations (PDF) |
| 382 | A fixed site of DNA replication in eucaryotic cells | 33.7 | 706 | Citations (PDF) |
| 383 | Protein factor(s) from mitotic CHO cells induce meiotic maturation in Xenopus laevis
oocytes | 2.7 | 96 | Citations (PDF) |
| 384 | Supercoiled loops and eucaryotic DNA replication | 33.7 | 623 | Citations (PDF) |
| 385 | Divergence of primate ribosomal RNA genes as assayed by restriction enzyme analysis | 2.3 | 11 | Citations (PDF) |
| 386 | The relationship of the nuclear matrix to cellular structure and function | 3.5 | 103 | Citations (PDF) |
| 387 | Continuous sampling as a pharmacokinetic tool | 4.7 | 15 | Citations (PDF) |
| 388 | RNA-DNA hybridization in solution without DNA reannealing | 2.1 | 31 | Citations (PDF) |
| 389 | The pharmacokinetics of amikacin in children | 2.0 | 66 | Citations (PDF) |
| 390 | Invasive Aspergillosis | 34.6 | 119 | Citations (PDF) |
| 391 | Evolutionary dynamics of cancer in response to targeted combination therapy | 1.6 | 567 | Citations (PDF) |
| 392 | Diagnostic potential of tumor DNA from ovarian cyst fluid | 1.6 | 38 | Citations (PDF) |
| 393 | Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy | 1.6 | 145 | Citations (PDF) |
| 394 | Supervised mutational signatures for obesity and other tissue-specific etiological factors in cancer | 1.6 | 16 | Citations (PDF) |
| 395 | Alpha-1 adrenergic receptor antagonists to prevent hyperinflammation and death from lower respiratory tract infection | 1.6 | 29 | Citations (PDF) |
| 396 | Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscape | 1.6 | 0 | Citations (PDF) |
| 397 | ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1 | 1.6 | 0 | Citations (PDF) |
| 398 | Detection of Cancers Three Years prior to Diagnosis Using Plasma Cell-Free DNA | 25.1 | 8 | Citations (PDF) |
| 399 | Detection of Human Brain Cancers using Genomic and Immune Cell Characterization of Cerebrospinal Fluid through CSF-BAM | 25.1 | 1 | Citations (PDF) |
| 400 | Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial | 33.0 | 6 | Citations (PDF) |
| 401 | TRBC2-targeting antibody–drug conjugates for the treatment of T cell cancers | 22.5 | 1 | Citations (PDF) |
| 402 | Bispecific antibodies and CAR T cells targeting a TP53 mutation–associated neoantigen show discordant affinity requirements | 10.6 | 0 | Citations (PDF) |
